Skip to main content

Advertisement

Table 1 Patient characteristics

From: Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)

  Study Group Total
  70 to 75 years > 75 years  
  80 mg/m2 (n = 15) 90 mg/m2 (n = 14) 60 mg/m2 (n = 7) 70 mg/m2 (n = 8) (n = 44)
Median age (range, in years) 73 (71 to 74) 73 (71 to 74) 79 (76 to 84) 77 (76 to 85) 74 (71 to 75)
Gender      
   Male 12 12 5 5 34 (77%)
   Female 3 2 2 3 10 (23%)
Karnofsky performance status      
   70 8 7 4 3 22 (50%)
   80 – 90 7 7 3 5 22 (50%)
Stage:      
   IIIA 5 1 - 2 8 (18%)
   IIIB 5 8 3 1 17 (39%)
   IV 5 5 4 5 19 (43%)
Histology:      
   Squamous cell carcinoma 9 5 2 7 23 (52%)
   Adenocarcinoma 3 7 3 - 13 (30%)
   Others 3 2 2 1 8 (18%)